These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38982323)

  • 1. Multireceptor Analysis for Evaluating the Antidiabetic Efficacy of Karanjin: A Computational Approach.
    Nag S; Stany B; Mishra S; Kumar S; Mohanto S; Ahmed MG; Mathew B; Subramaniyan V
    Endocrinol Diabetes Metab; 2024 Jul; 7(4):e509. PubMed ID: 38982323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights of anti-diabetic compounds and its hyaluronic acid conjugates against aldose reductase enzyme through molecular modeling and simulations study-a novel treatment option for inflammatory diabetes.
    Jayabal D; Jayanthi S; Thirumalaisamy R; Shimu MSS
    J Mol Model; 2023 Jul; 29(8):238. PubMed ID: 37420135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis.
    Kaya S; Tatar-Yılmaz G; Aktar BSK; Emre EEO
    Protein J; 2024 Jun; 43(3):577-591. PubMed ID: 38642318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and anti-inflammatory properties of karanjin (Pongamia pinnata seed) and its derivatives.
    Rekha MJ; Bettadaiah BK; Muthukumar SP; Govindaraju K
    Bioorg Chem; 2021 Jan; 106():104471. PubMed ID: 33257003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the antihyperglycemic potential of tetrapeptides devised from AdMc1
    Mustafa G; Mahrosh HS; Zafar M; Attique SA; Arif R
    Int J Immunopathol Pharmacol; 2022; 36():3946320221103120. PubMed ID: 35574607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of human pancreatic alpha-amylase inhibitors from Physalis peruviana for the treatment of type 2 diabetes.
    Tiwari VP; Dubey A; Al-Shehri M; Tripathi IP
    J Biomol Struct Dyn; 2024; 42(2):1031-1046. PubMed ID: 37545158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (
    Ahmed S; Ali MC; Ruma RA; Mahmud S; Paul GK; Saleh MA; Alshahrani MM; Obaidullah AJ; Biswas SK; Rahman MM; Rahman MM; Islam MR
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889399
    [No Abstract]   [Full Text] [Related]  

  • 11. Computer-Aided Screening of Phytoconstituents from
    Sajal H; Patil SM; Raj R; Shbeer AM; Ageel M; Ramu R
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
    Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
    [No Abstract]   [Full Text] [Related]  

  • 16. Compounds Identified from Marine Mangrove Plant
    Aljahdali MO; Molla MHR; Ahammad F
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational investigation of 2, 4-Di Tert Butyl Phenol as alpha amylase inhibitor isolated from Coccinia grandis (L.) Voigt using molecular docking, and ADMET parameters.
    Momin YH; Yeligar VC; Saralaya MG; Dharmamoorthy G; Mallikarjuna BP; Jadhav ST; Das K; Almuqbil M; Ahmad F; Rabbani SI; Asdaq SMB
    Comput Biol Chem; 2024 Jun; 110():108087. PubMed ID: 38718496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.
    Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI
    Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
    Thakral S; Singh V
    Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.